Gene · 10313
NIH grants668
NIH grants whose papers are about the gene, through NIH's grant-paper links.
141 to 160 of 668
Download this page as JSON| Grant | Title | RTN3 papers | Newest fiscal year |
|---|---|---|---|
| R01NS117440 | The connection between ER-phagy, ER structure and hereditary spastic paraplegias | 1 | 2024 |
| R01NS129553 | The Role of Lysosomal Membrane Permeabilization and Cathepsin B Release in Stroke Brain Injury | 1 | 2024 |
| R21DA056729 | Deciphering the complex pharmacology of CB1: towards the understanding of a third signaling pathway | 1 | 2024 |
| R37AI064046 | APOBEC3 Proteins in HIV Restriction | 1 | 2024 |
| T32CA078207 | Training Program in Cancer Biology | 1 | 2024 |
| T32DK007245 | Training Program in Endocrinology and Metabolism | 1 | 2024 |
| T32GM007863 | Michigan Medical Scientist Training Program | 1 | 2024 |
| T32HS000084 | The University of Chicago and Northwestern University Predoctoral Health Services Research Program-Renewal | 1 | 2024 |
| U01AG032984 | Alzheimer's Disease Genetics Consortium | 1 | 2024 |
| U01CA243004 | Multiscale analysis of metabolic inflammation as a driver of breast cancer | 1 | 2024 |
| U01NS114144 | Blood test to aid treatment decisions for perinatal asphyxiation | 1 | 2024 |
| ZIAAG000959 | Striosomes Constrain Locomotor Vigor in Parkinson's disease and Other Movement Disorders | 1 | 2024 |
| RF1AG058261 | Role of the CX3CL1 C-terminus in reversing age-dependent Alzheimers neurodegeneration | 3 | 2023 |
| F31DK128868 | Investigating the role of ER-phagy in proinsulin quality control | 2 | 2023 |
| F31CA247395 | A patient-specific hiPSC model of breast cancer to identify genetic determinants of subclonal response and resistance to PARP inhibitors | 1 | 2023 |
| F31NS124088 | Investigating how nuclear pore components exploit an ER-dependent quality control pathway | 1 | 2023 |
| P01AG015379 | Presenilin Biology and the Mechanisms of Alzheimer's Disease | 1 | 2023 |
| P01CA114046 | Targeted Therapies in Melanoma | 1 | 2023 |
| P01CA165997 | The Role of the Integrated Stress Response in Cancer | 1 | 2023 |
| R01AA018071 | Physiology/Pathophysiology of Vitamin B1 Transport in Pancreatic Acinar Cells | 1 | 2023 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10313/grants?page=8